Skip to main content
. 2025 Sep 27;17(10):1268. doi: 10.3390/pharmaceutics17101268
PZQ Praziquantel
OXA Oxamniquine
Sm Schistosoma mansoni
Sh S. haematobium
DALYs Disability-adjusted life year
MDA Mass drug administration
TRPMPZQ Transient receptor potential channel
HYC Hycanthone
SmSULT S. mansoni sulfotransferase
PAPS 3′-phosphoadenosine 5′-phosphosulfate
SULT Sulfotransferase
ShSULT S. haematobium sulfotransferase
qPCR Quantitative polymerase chain reaction
PZQ-R PZQ-resistant